FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096027559> ?p ?o ?g. }

• W3096027559 endingPage "111390" @default.
• W3096027559 startingPage "111390" @default.
• W3096027559 abstract "Cutaneous leishmaniasis is a worldwide public health problem. Conventional therapies, in addition to the high cost, have many adverse effects and cases of parasite's resistance. Chalcones are secondary metabolites precursors in the flavonoid pathway and can be obtained naturally, but with low yield from plant raw material. Thus, the use of synthetic chalcones has been a promising strategy for the development of molecules with leishmanicidal activity. Thus, this work aimed to develop a controlled release system of two synthetic chalcone (trans-chalcones and 3'-(trifluormethyl)-chalcone) using polyvinyl alcohol nanofibers (PVA) as scaffold. The association of chalcones to the nanofibers was made by nanoemulsions (NE) thereof, i.e., a colloidal system on a nanometric scale, which allows compounds with opposite polarities to remain miscible and stable throughout their manipulation. Chalcone nanoemulsions were developed using the spontaneous emulsification technique. The NE were characterized regarding their particle size, polydispersion index (PDI), and zeta potential. The results showed NE with spherical shape, absolute values of zeta potential were higher than 30 mV and homogeneous distribution pattern (PDI < 0.3). Dynamics light scattering (DLS) analysis showed similar hydrodynamic rays, i.e., 180 nm (trans-chalcone NE) and 178 nm (NE containing 3'-(trifluormethyl)-chalcone, in addition to presenting encapsulation efficiency values close to 100 %. Subsequently, the NE were added to a polymeric solution of polyvinyl alcohol (PVA) and processed via the electrospinning technique affording a PVA matrix (15 %, w/v) nanofiber containing the chalcones NE at 1 mg.mL-1. In a follow-up experiment, the skin permeation assay of the PVA matrix-chalcone NE was performed in vitro using Franz type diffusion cells and porcine ear as biological model of study. The results showed that the treatments with the nanofibers containing the chalcone NE were retained mainly in the stratum corneum, while the NE suspensions containing chalcone were retained in the epidermis and dermis. This result is thought to be relevant, since parasites are located mainly in the dermis. Further, in vitro assay against the amastigote form of L. (L) amazonensis, showed IC50 values to trans-chalcone and 3'-(trifluormethyl)-chalcone of 24.42 ± 6.76 μg.mL-1 and 15.36 ± 4.61 μg.mL-1, respectively. In addition to improving the solubility of the compounds tested in culture medium without using organic solvents, chalcones in nano-emulsified form reduced the IC50 to 9.09 ± 1.24 μg.mL-1 (trans-chalcone) and 10.27 ± 2.27 μg.mL-1 (3'-(trifluormethyl)-chalcone) which confirmed the potential of the nanoemulsion containing chalcone for cutaneous leishmaniasis treatment." @default.
• W3096027559 created "2020-11-09" @default.
• W3096027559 creator A5011409966 @default.
• W3096027559 creator A5011450167 @default.
• W3096027559 creator A5014861989 @default.
• W3096027559 creator A5043518143 @default.
• W3096027559 creator A5053051965 @default.
• W3096027559 creator A5059848478 @default.
• W3096027559 creator A5066501019 @default.
• W3096027559 creator A5071666561 @default.
• W3096027559 creator A5075670032 @default.
• W3096027559 creator A5089990109 @default.
• W3096027559 date "2021-02-01" @default.
• W3096027559 modified "2023-09-23" @default.
• W3096027559 title "Polyvinyl alcohol-based electrospun matrix as a delivery system for nanoemulsion containing chalcone against Leishmania (Leishmania) amazonensis" @default.
• W3096027559 cites W1878582649 @default.
• W3096027559 cites W1964374629 @default.
• W3096027559 cites W1994745504 @default.
• W3096027559 cites W1998862723 @default.
• W3096027559 cites W2017294860 @default.
• W3096027559 cites W2032095700 @default.
• W3096027559 cites W2033004671 @default.
• W3096027559 cites W2037117305 @default.
• W3096027559 cites W2066615805 @default.
• W3096027559 cites W2092546329 @default.
• W3096027559 cites W2100041796 @default.
• W3096027559 cites W2158363156 @default.
• W3096027559 cites W2326495514 @default.
• W3096027559 cites W2436294696 @default.
• W3096027559 cites W2475849143 @default.
• W3096027559 cites W2550229585 @default.
• W3096027559 cites W2588003319 @default.
• W3096027559 cites W2611909956 @default.
• W3096027559 cites W2689455564 @default.
• W3096027559 cites W2730840378 @default.
• W3096027559 cites W2778575379 @default.
• W3096027559 cites W2790526432 @default.
• W3096027559 cites W2790700924 @default.
• W3096027559 cites W2806977278 @default.
• W3096027559 cites W2888465197 @default.
• W3096027559 cites W2901244028 @default.
• W3096027559 cites W2903185971 @default.
• W3096027559 cites W2912891316 @default.
• W3096027559 cites W2925592421 @default.
• W3096027559 cites W3009539818 @default.
• W3096027559 cites W778585144 @default.
• W3096027559 doi "https://doi.org/10.1016/j.colsurfb.2020.111390" @default.
• W3096027559 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33208279" @default.
• W3096027559 hasPublicationYear "2021" @default.
• W3096027559 type Work @default.
• W3096027559 sameAs 3096027559 @default.
• W3096027559 citedByCount "12" @default.
• W3096027559 countsByYear W30960275592021 @default.
• W3096027559 countsByYear W30960275592022 @default.
• W3096027559 countsByYear W30960275592023 @default.
• W3096027559 crossrefType "journal-article" @default.
• W3096027559 hasAuthorship W3096027559A5011409966 @default.
• W3096027559 hasAuthorship W3096027559A5011450167 @default.
• W3096027559 hasAuthorship W3096027559A5014861989 @default.
• W3096027559 hasAuthorship W3096027559A5043518143 @default.
• W3096027559 hasAuthorship W3096027559A5053051965 @default.
• W3096027559 hasAuthorship W3096027559A5059848478 @default.
• W3096027559 hasAuthorship W3096027559A5066501019 @default.
• W3096027559 hasAuthorship W3096027559A5071666561 @default.
• W3096027559 hasAuthorship W3096027559A5075670032 @default.
• W3096027559 hasAuthorship W3096027559A5089990109 @default.
• W3096027559 hasConcept C106487976 @default.
• W3096027559 hasConcept C136764020 @default.
• W3096027559 hasConcept C178790620 @default.
• W3096027559 hasConcept C185592680 @default.
• W3096027559 hasConcept C203014093 @default.
• W3096027559 hasConcept C2776555147 @default.
• W3096027559 hasConcept C2778551929 @default.
• W3096027559 hasConcept C2780764945 @default.
• W3096027559 hasConcept C2781092759 @default.
• W3096027559 hasConcept C41008148 @default.
• W3096027559 hasConcept C43617362 @default.
• W3096027559 hasConcept C71924100 @default.
• W3096027559 hasConcept C71928629 @default.
• W3096027559 hasConcept C98274493 @default.
• W3096027559 hasConceptScore W3096027559C106487976 @default.
• W3096027559 hasConceptScore W3096027559C136764020 @default.
• W3096027559 hasConceptScore W3096027559C178790620 @default.
• W3096027559 hasConceptScore W3096027559C185592680 @default.
• W3096027559 hasConceptScore W3096027559C203014093 @default.
• W3096027559 hasConceptScore W3096027559C2776555147 @default.
• W3096027559 hasConceptScore W3096027559C2778551929 @default.
• W3096027559 hasConceptScore W3096027559C2780764945 @default.
• W3096027559 hasConceptScore W3096027559C2781092759 @default.
• W3096027559 hasConceptScore W3096027559C41008148 @default.
• W3096027559 hasConceptScore W3096027559C43617362 @default.
• W3096027559 hasConceptScore W3096027559C71924100 @default.
• W3096027559 hasConceptScore W3096027559C71928629 @default.
• W3096027559 hasConceptScore W3096027559C98274493 @default.
• W3096027559 hasLocation W30960275591 @default.
• W3096027559 hasOpenAccess W3096027559 @default.
• W3096027559 hasPrimaryLocation W30960275591 @default.
• W3096027559 hasRelatedWork W1733625577 @default.

• next